D. Jane Taylor

872 total citations
29 papers, 568 citations indexed

About

D. Jane Taylor is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Genetics. According to data from OpenAlex, D. Jane Taylor has authored 29 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in D. Jane Taylor's work include Reproductive Health and Contraception (7 papers), Ovarian function and disorders (5 papers) and Estrogen and related hormone effects (5 papers). D. Jane Taylor is often cited by papers focused on Reproductive Health and Contraception (7 papers), Ovarian function and disorders (5 papers) and Estrogen and related hormone effects (5 papers). D. Jane Taylor collaborates with scholars based in United States and United Kingdom. D. Jane Taylor's co-authors include R.D. Bulbrook, Daniel R. Mishell, Arthur E. Bogdén, Henry J. Esber, Alexander Melamed, Melissa Natavio, Juan C. Felix, Jessica Atrio, Daniel Grossman and Marji Gold and has published in prestigious journals such as Journal of the American Chemical Society, JNCI Journal of the National Cancer Institute and American Journal of Epidemiology.

In The Last Decade

D. Jane Taylor

27 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Jane Taylor United States 13 246 139 110 101 99 29 568
O Peralta Chile 19 373 1.5× 172 1.2× 93 0.8× 69 0.7× 106 1.1× 38 938
G Riotton United States 11 213 0.9× 69 0.5× 40 0.4× 44 0.4× 185 1.9× 22 462
S.J. Steele United States 17 287 1.2× 104 0.7× 387 3.5× 129 1.3× 143 1.4× 38 1.2k
Valerie Montgomery Rice United States 16 232 0.9× 91 0.7× 251 2.3× 103 1.0× 60 0.6× 41 902
Rochelle Fradkin United States 15 257 1.0× 60 0.4× 19 0.2× 44 0.4× 144 1.5× 23 629
Feiyang Diao China 14 277 1.1× 111 0.8× 277 2.5× 230 2.3× 153 1.5× 53 799
Chunyan He United States 15 97 0.4× 198 1.4× 118 1.1× 55 0.5× 86 0.9× 27 743
M. Bush United States 9 134 0.5× 44 0.3× 95 0.9× 21 0.2× 85 0.9× 19 409
Michael Weigel Germany 10 110 0.4× 37 0.3× 150 1.4× 28 0.3× 37 0.4× 32 504
Torsten Frambach Germany 12 470 1.9× 62 0.4× 431 3.9× 42 0.4× 110 1.1× 23 689

Countries citing papers authored by D. Jane Taylor

Since Specialization
Citations

This map shows the geographic impact of D. Jane Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Jane Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Jane Taylor more than expected).

Fields of papers citing papers by D. Jane Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Jane Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Jane Taylor. The network helps show where D. Jane Taylor may publish in the future.

Co-authorship network of co-authors of D. Jane Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of D. Jane Taylor. A scholar is included among the top collaborators of D. Jane Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Jane Taylor. D. Jane Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biggs, M. Antonia, et al.. (2025). Accuracy of survey-based assessment of eligibility for medication abortion compared with clinician assessment. American Journal of Obstetrics and Gynecology. 233(1). 44.e1–44.e15. 1 indexed citations
2.
Raymond, Elizabeth G., Daniel Grossman, Alice Mark, et al.. (2020). Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond. Contraception. 101(6). 361–366. 119 indexed citations
3.
Brache, Vivian, Ruth Merkatz, Narender Kumar, et al.. (2015). A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women. Contraception. 92(4). 289–297. 11 indexed citations
4.
Hovanessian‐Larsen, Linda, D. Jane Taylor, Debra Hawes, et al.. (2012). Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception. 86(3). 238–243. 4 indexed citations
5.
Natavio, Melissa, D. Jane Taylor, Paul D. Blumenthal, et al.. (2012). Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system. Contraception. 87(4). 426–431. 28 indexed citations
6.
Taylor, D. Jane, et al.. (2012). Immediate Post-Abortion Insertion of Intrauterine Contraceptives (IUC) in a Diverse Urban Population. Journal of Immigrant and Minority Health. 16(3). 416–421. 5 indexed citations
7.
Taylor, D. Jane, et al.. (2010). Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability. Contraception. 82(6). 491–496. 57 indexed citations
8.
Taylor, D. Jane, et al.. (2010). Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously. Contraception. 81(6). 487–495. 34 indexed citations
9.
Taylor, D. Jane, Celeste Leigh Pearce, Linda Hovanessian‐Larsen, et al.. (2009). Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Research and Treatment. 118(1). 161–168. 24 indexed citations
10.
11.
Giovanella, Beppino C., Leo J. Williams, D. Jane Taylor, et al.. (1991). Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the her‐2/neu oncogene. International Journal of Cancer. 47(1). 66–71. 50 indexed citations
12.
Bulbrook, R.D. & D. Jane Taylor. (1983). Commentaries on research in breast disease. Medical Entomology and Zoology. 54 indexed citations
13.
Halberg, F, Warren O. Nelson, Françis Lévi, et al.. (1980). Chronotherapy of mammary cancer in rats.. PubMed. 7(2). 85–99. 9 indexed citations
14.
Bogdén, Arthur E., et al.. (1974). The effect of perphenazine-induced serum prolactin response on estrogen-primed mammary tumor-host systems, 13762 and R-35 mammary adenocarcinomas.. PubMed. 34(11). 3018–25. 12 indexed citations
15.
Esber, Henry J., Elizabeth Valentine, D. Jane Taylor, & Arthur E. Bogdén. (1973). Immunoadjuvant Activity of Bacterial Fractions on Antibody-Forming Cells During the Primary Immune Response Period. Immunological Communications. 2(6). 585–595. 3 indexed citations
16.
Carroll, F. Ivy, et al.. (1972). Antitumor and antileukemic effects of some steroids and other biologically interesting compounds containing an alkylating agent. Journal of Medicinal Chemistry. 15(11). 1158–1161. 24 indexed citations
17.
Esber, Henry J., et al.. (1972). Nonspecific stimulation of tumor-associated immunity by methanol-soluble fraction of Mycobacterium butyricum.. PubMed. 32(4). 795–803. 5 indexed citations
18.
Taylor, D. Jane, et al.. (1959). Studies of the Virulence of Monobacterial Cultures of One Strain of Entamoeba histolytica in the Guinea Pig. Journal of Parasitology. 45(3). 269–269. 1 indexed citations
19.
Taylor, D. Jane, et al.. (1954). AMEBACIDAL ACTIVITY OF PUROMYCIN1 IN THE GUINEA PIG. Journal of the American Chemical Society. 76(17). 4497–4497. 7 indexed citations
20.
Josephson, Edward S., et al.. (1951). A METABOLITE OF PAMAQUINE FROM CHICKENS. Journal of Pharmacology and Experimental Therapeutics. 103(1). 7–9. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O Peralta Breakdown of academic impact, for papers by G Riotton Breakdown of academic impact, for papers by S.J. Steele Breakdown of academic impact, for papers by Valerie Montgomery Rice Breakdown of academic impact, for papers by Rochelle Fradkin Breakdown of academic impact, for papers by Feiyang Diao Breakdown of academic impact, for papers by Chunyan He Breakdown of academic impact, for papers by M. Bush Breakdown of academic impact, for papers by Michael Weigel Breakdown of academic impact, for papers by Torsten Frambach
Rankless by CCL
2026